RE: Blockbuster Drug $1 billion worth in future28 Nov 2019 12:36
Good to see some of the old lads hanging in here still. Ofcourse NoLupus to keep everyone's feet on the ground.
With Phase 3 trial now funded and ready to kick off in 2020, we should see the gradual rise in SP from here on. Just before the P3 trial results SP was at £1.50 rising from 35p. This time it has potential to go even higher so hang on until then. In one year time, the current SP will look lot cheaper.
Avion had done due diligence and must be very confident on Lupuzor to invest in P3 trial. The trial design is already agreed with FDA. With 1.5M patients just in US who are in need of Lupuzor, there is a potential for billion dollar revenue. Also there could be more partner news for marketing Lupuzor outside of US. ATB